Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Harris Endorsement pledge to legalize :) $$$$$$
View:
Post by 1hot-techwoman on Jul 22, 2024 11:17am

Harris Endorsement pledge to legalize :) $$$$$$

DJ Cannabis Stocks Gain After Biden's Harris Endorsement

Monday, July 22, 2024, 11:01 AM ET
 

By Dean Seal

Shares of cannabis companies are getting a lift after President Joe Biden said he wouldn't run for reelection and endorsed Vice President Kamala Harris as the Democratic nominee.

Harris has been consistently supportive of cannabis reform in recent years. In March, she called for cannabis to be reclassified to a less dangerous drug category "as quickly as possible."

AdvisorShares Pure US Cannabis, a popular exchange-traded fund tracking marijuana stocks, was up 4.7% at $7.76 in early trading.

Shares of Canopy Growth were up 11% at $7.92, while shares of TerrAscend jumped 8.6% to $1.39 and Verano Holdings shares climbed 6% to $4.03. The stocks of bigger cannabis firms, including Curaleaf Holdings, Green Thumb Industries and Trulieve Cannabis, were up between 3% and 4%.

Given the high probability that Harris will become the formal Democratic nominee, Biden's change-up shouldn't impact his administration's efforts to reschedule cannabis this year, Alliance Global Partners analyst Aaron Grey said in a research note.

"In fact, a final rule rescheduling cannabis to Schedule III (from Schedule I) could further demonstrate the ability of the Biden administration (of which VP Harris is a part) to execute on a promise to voters," Grey said Monday.

The comment period for a proposed rule enacting the rescheduling ended on Monday. The Department of Justice has the final say on whether the rule gets finalized.
Comment by QContinuum1 on Jul 22, 2024 12:19pm
And yet the impacts on LABS is SQRT(Flock_all).  It is becoming laughable how LABS is simply a cork in the sea getting bashed around, while other businesses seem to navigate the waters for good or bad. Looking forward to Pidduck and Hunter giving us forward guidance on income statement and actually some words on SP appreciation strategies.  Doing nothing is not an option at this point ...more  
Comment by Solid1 on Jul 22, 2024 2:13pm
Medipharm labs targets the pharmaceutical market. Legalization does not play a role here; in fact, it would be rather bad for the labs if it came to full legalization
Comment by okgonow on Jul 22, 2024 2:48pm
Full leagalization is still light years away in the US. There is no way the righteous right will have any part of that. And by the looks thy will be in the driver's seat as of next year?!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities